Portfolio

Inbiomotion and SPA – Società Prodotti Antibiotici (SPA Farma) sign an exclusive agreement for MAF Test in Italy

October 10, 2024

SPA Farma, a leading pharmaceutical company of innovative healthcare products and diagnostic tools, and Inbiomotion, proprietors of MAF Test for identifying high risk early-stage breast cancer patients, have signed an exclusive agreement to start offering the MAF Test in Italy.

 

Read more